Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Navigation/Suche

• Forscher*innen.
• Institutionen.
• Projekte.
• Publikationen.
• Partner.
• Geldgeber.
• Ausstattung.
• Knowhow.
• Forschungsfelder.

Gewählte Publikation:

Binder, F.
SGLT2 Inhibitors in Heart Failure: A Systematic Review of Therapeutic Effects Across Ejection Fraction and Diabetic Status
Humanmedizin; [ Diplomarbeit ] Medizinische Universität Graz; 2025. pp. 57 [OPEN ACCESS]
FullText

 

Autor*innen der Med Uni Graz:

Betreuer*innen:

ATALLAH Reham

Heinemann Akos

Altmetrics:

Abstract:

Sodium-glucose cotransporter 2 (SGLT2) inhibitors have emerged as a novel therapeutic option in heart failure (HF), originally introduced for the management of type 2 diabetes. Recent evidence has highlighted their cardiovascular and renal benefits in both diabetic and non-diabetic patients with HF. However, their efficacy across the full spectrum of HF phenotypes, particularly in regard to key clinical outcomes, remains an area of active investigation.

© Med Uni Graz • Impressum